How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/cholinesterase-inhibitors-toxicity.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Cholinesterase Inhibitors Toxicity — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cholinesterase Inhibitors Toxicity (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Cholinesterase Inhibitors Toxicity, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Pralidoxime Chloride (Autoinjector)	PRALIDOXIME	Baxter	Cholinesterase Reactivator	Acetylcholinesterase		1964-01-01
(-)-Atropine	Hyoscyamine	University of Kansas Medical Center	hyoscyamine	Muscarinic acetylcholine receptor M4

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Baxter · 1 drug in Cholinesterase Inhibitors Toxicity
University of Kansas Medical Center · 1 drug in Cholinesterase Inhibitors Toxicity

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Cholinesterase Inhibitors Toxicity:

Cite this brief

Drug Landscape (2026). Cholinesterase Inhibitors Toxicity — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/cholinesterase-inhibitors-toxicity. Accessed 2026-06-10.

Cholinesterase Inhibitors Toxicity full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing